http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2314388-C3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 1973-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1979-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1979-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-2314388-C3
titleOfInvention Drugs with anti-tumor effects with a content of pibromine
priorityDate 1972-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID202981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451431623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453387816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587

Total number of triples: 29.